CARLOS RAMOS to Antigens, Neoplasm
This is a "connection" page, showing publications CARLOS RAMOS has written about Antigens, Neoplasm.
Connection Strength
0.308
-
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425.
Score: 0.114
-
Cellular Immunotherapy in Lymphoma: Beyond CART Cells. Curr Treat Options Oncol. 2020 02 11; 21(3):21.
Score: 0.107
-
In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes. PLoS Comput Biol. 2022 03; 18(3):e1009883.
Score: 0.031
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
Score: 0.029
-
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma. Sci Transl Med. 2020 07 29; 12(554).
Score: 0.028